{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:10:19Z","timestamp":1793927419802,"version":"4.8.0"},"reference-count":40,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2021.0009","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T21:49:37Z","timestamp":1612993777000},"source":"Crossref","is-referenced-by-count":23,"title":["Neonatal Screening for Congenital Metabolic and Endocrine Disorders"],"prefix":"10.3238","author":[{"given":"Anja","family":"L\u00fcders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Blankenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inken","family":"Brockow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Ensenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Nennstiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"10.3238\/arztebl.m2021.0009_ref1","unstructured":"Richtlinie des Gemeinsamen Bundesausschusses \u00fcber die Fr\u00fcherkennung von Krankheiten bei Kindern (Kinder-Richtlinie), 2020; \u00a7\u00a7\u00a013\u201328. www.g-ba.de\/downloads\/62-492-2156\/Kinder-RL_2020-05-14_iK-2020-03-25.pdf (last accessed on 15 July 2020)."},{"key":"10.3238\/arztebl.m2021.0009_ref2","unstructured":"Richtlinie des Gemeinsamen Bundesausschusses \u00fcber die Fr\u00fcherkennung von Krankheiten bei Kindern (Kinder-Richtlinie), 2020; \u00a7\u00a7\u00a029\u201342. www.g-ba.de\/downloads\/62-492-2156\/Kinder-RL_2020-05-14_iK-2020-03-25.pdf (last accessed on 15 July 2020)."},{"key":"10.3238\/arztebl.m2021.0009_ref3","doi-asserted-by":"crossref","unstructured":"Nennstiel-Ratzel U, L\u00fcders A, Blankenstein O: Neugeborenenscreening: ein Paradebeispiel f\u00fcr effektive Sekund\u00e4rpr\u00e4vention. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2015; 58: 139\u201345","DOI":"10.1007\/s00103-014-2092-3"},{"key":"10.3238\/arztebl.m2021.0009_ref4","unstructured":"Gesetz \u00fcber genetische Untersuchungen am Menschen (Gendiagnostikgesetz- GenDG), Ausfertigungsdatum 31.07.2009. www.gesetze-im-internet.de\/gendg\/BJNR252900009.html (last accessed on 15 July 2020)."},{"key":"10.3238\/arztebl.m2021.0009_ref5","unstructured":"Nennstiel U, L\u00fcders A, Blankenstein O, et al.: DGNS Screening Reports. www.screening-dgns.de\/reports.php (last accessed on 15 July 2020)."},{"key":"10.3238\/arztebl.m2021.0009_ref6","doi-asserted-by":"crossref","unstructured":"Nennstiel-Ratzel U, Liebl B, Zapf A: Modellprojekt zur Neuordnung des Neugeborenen-Screenings in Bayern. Gesundheitswesen 2003; 65: S31\u20135","DOI":"10.1055\/s-2003-38117"},{"key":"10.3238\/arztebl.m2021.0009_ref7","doi-asserted-by":"crossref","unstructured":"Liebl B, Nennstiel-Ratzel U, von Kries R, et al.: Expanded newborn screening in Bavaria: tracking to achieve requested repeat testing. Prev Med 2002; 34: 132\u20137","DOI":"10.1006\/pmed.2001.0954"},{"key":"10.3238\/arztebl.m2021.0009_ref8","doi-asserted-by":"crossref","unstructured":"Liebl B, Nennstiel-Ratzel U, von Kries R, et al.: Very high compliance in an expanded MS-MS-based newborn screening program despite written parental consent. Prev Med 2002; 34: 127\u201331","DOI":"10.1006\/pmed.2001.0952"},{"key":"10.3238\/arztebl.m2021.0009_ref9","doi-asserted-by":"crossref","unstructured":"Liebl B, von Kries R, Nennstiel-Ratzel U, et al.: Ethisch-rechtliche Aspekte des Neugeborenenscreenings. Monatsschr Kinderheilkd 2001; 149: 1326\u201335","DOI":"10.1007\/s001120170019"},{"key":"10.3238\/arztebl.m2021.0009_ref10","unstructured":"Statistisches Bundesamt Deutschland \u2013 GENESIS-Online: Ergebnis 12612\u20130001 (destatis.de) (last accessed on 15 July 2020)."},{"key":"10.3238\/arztebl.m2021.0009_ref11","doi-asserted-by":"crossref","unstructured":"Burgard P, Rupp K, Lindner M, et al.: Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance. J Inherit Metab Dis 2012; 35: 613\u201325","DOI":"10.1007\/s10545-012-9484-z"},{"key":"10.3238\/arztebl.m2021.0009_ref12","doi-asserted-by":"crossref","unstructured":"Odenwald B, D\u00f6rr HG, Bonfig W, et al.: Classic congenital adrenal hyperplasia due to 21-hydroxylase-deficiency: 13 years of neonatal screening and follow-up in Bavaria. Klin Padiatr 2015; 227: 278\u201383","DOI":"10.1055\/s-0035-1554639"},{"key":"10.3238\/arztebl.m2021.0009_ref13","doi-asserted-by":"crossref","unstructured":"M\u00fctze U, Garbade S, Gramer G, et al.: Long-term outcomes of individuals with metabolic diseases identified through newborn screening. Pediatrics 2020; DOI: 10.1542\/peds.2020\u20130444 (epub ahead of print)","DOI":"10.1542\/peds.2020-0444"},{"key":"10.3238\/arztebl.m2021.0009_ref14","doi-asserted-by":"crossref","unstructured":"Schweitzer-Krantz S: Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia. Eur J Pediatr 2003; 162: S50\u20133","DOI":"10.1007\/s00431-003-1352-2"},{"key":"10.3238\/arztebl.m2021.0009_ref15","doi-asserted-by":"crossref","unstructured":"Leger J, Olivieri A, Donaldson M, et al.: European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm Res Paediatr 2014; 81: 80\u2013103","DOI":"10.1159\/000358198"},{"key":"10.3238\/arztebl.m2021.0009_ref16","doi-asserted-by":"crossref","unstructured":"Schlune A, Riederer A, Mayatepek E, Ensenauer R: Aspects of newborn screening in isovalerica acidemia. Int J Neonatal Screen 2018; DOI: 10.3390\/ijns4010007","DOI":"10.3390\/ijns4010007"},{"key":"10.3238\/arztebl.m2021.0009_ref17","doi-asserted-by":"crossref","unstructured":"Nennstiel-Ratzel U, Arenz S, Maier EM, et al.: Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>Gidentified by neonatal screening. Mol Genet Metab 2005; 85: 157\u20139","DOI":"10.1016\/j.ymgme.2004.12.010"},{"key":"10.3238\/arztebl.m2021.0009_ref18","doi-asserted-by":"crossref","unstructured":"El-Helou SM, Biegner AK, Bode S, et al.: The German National Registry of Primary Immunodeficiencies (2012\u20132017). Front Immunol 2019; 10; DOI: 10.3389\/fimmu.2019.01272","DOI":"10.3389\/fimmu.2019.01272"},{"key":"10.3238\/arztebl.m2021.0009_ref19","unstructured":"N\u00e4hrlich L (ed.), Burkhard J, Wosniok J: Deutsches Mukoviszidose-Register Berichtsband 2018. www.muko.info\/fileadmin\/user_upload\/angebote\/qualitaetsmanagement\/register\/berichtsbaende\/berichtsband_2018.pdf (last accessed on 15 July 2020)."},{"key":"10.3238\/arztebl.m2021.0009_ref20","doi-asserted-by":"crossref","unstructured":"Ebrahimi-Fakhari D, Zemlin M, Sauer H, Poryo M, Graf N, Meyer S: Erhebungseinheit f\u00fcr seltene p\u00e4diatrische Erkrankungen in Deutschland (ESPED) \u2013 25 Jahre p\u00e4diatrische Epidemiologie: Eine Bestandsaufnahme. Klin Padiatr 2018; 230: 215\u201324","DOI":"10.1055\/a-0586-4365"},{"key":"10.3238\/arztebl.m2021.0009_ref21","doi-asserted-by":"crossref","unstructured":"Shai S, Perez-Becker R, Andres O, et al.: Incidence of SCID in Germany from 2014 to 2015. An ESPED survey on behalf of the API Erhebungseinheit f\u00fcr seltene padiatrische Erkrankungen in Deutschland (German Paediatric Surveillance Unit). J Clin Immunol 2020; 40: 708\u201317","DOI":"10.1007\/s10875-020-00782-x"},{"key":"10.3238\/arztebl.m2021.0009_ref22","doi-asserted-by":"crossref","unstructured":"Hoffmann GF, Lindner M, Loeber JG: 50 years of newborn screening. J Inherit Metab Dis 2014; 37: 163\u20134","DOI":"10.1007\/s10545-014-9688-5"},{"key":"10.3238\/arztebl.m2021.0009_ref23","doi-asserted-by":"crossref","unstructured":"Starkweather A, Coleman B, Barcelona de Mendoza V, et al.: Policy brief: improve coverage of newborn genetic screening to include the Recommended Uniform Screening Panel and newborn screening registry. Nurs Outlook 2017; 65: 480\u20134","DOI":"10.1016\/j.outlook.2017.04.009"},{"key":"10.3238\/arztebl.m2021.0009_ref24","doi-asserted-by":"crossref","unstructured":"Cornel MC, Rigter T, Weinreich SS, et al.: A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document. Eur J Hum Genet 2014; 22: 12\u20137","DOI":"10.1038\/ejhg.2013.90"},{"key":"10.3238\/arztebl.m2021.0009_ref25","doi-asserted-by":"crossref","unstructured":"Kanungo S, Patel DR, Neelakantan M, Ryali B: Newborn screening and changing face of inborn errors of metabolism in the United States. Ann Transl Med 2018; 6: 468 CrossRef","DOI":"10.21037\/atm.2018.11.68"},{"key":"10.3238\/arztebl.m2021.0009_ref26","doi-asserted-by":"crossref","unstructured":"Lund AM, Hougaard DM, Simonsen H, et al.: Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland \u2013 experience and development of a routine program for expanded newborn screening. Mol Genet Metab 2012; 107: 281\u201393","DOI":"10.1016\/j.ymgme.2012.06.006"},{"key":"10.3238\/arztebl.m2021.0009_ref27","doi-asserted-by":"crossref","unstructured":"Mandrik O, Zielonke N, Meheus F, et al.: Systematic reviews as a \u201alens of evidence\u2018: determinants of benefits and harms of breast cancer screening. Int J Cancer 2019; 145: 994\u20131006 MEDLINE","DOI":"10.1002\/ijc.32211"},{"key":"10.3238\/arztebl.m2021.0009_ref28","unstructured":"Nennstiel U, Brockow I, S\u00f6hl K, et al.: Endbericht zur Evaluation des Neugeborenen-H\u00f6rscreenings 2011\/2012, Stand 15.01.2017. www.g-ba.de\/downloads\/17-98-4329\/2017-05-18_Kinder-RL_Annahme_Endbericht_NHS-Bericht.pdf (last accessed on 15 July 2020)."},{"key":"10.3238\/arztebl.m2021.0009_ref29","doi-asserted-by":"crossref","unstructured":"Janzen N, Sander S, Terhardt M, Peter M, Sander J: Fast and direct quantification of adrenal steroids by tandem mass spectrometry in serum and dried blood spots. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 861: 117\u201322","DOI":"10.1016\/j.jchromb.2007.11.006"},{"key":"10.3238\/arztebl.m2021.0009_ref30","doi-asserted-by":"crossref","unstructured":"Janzen N, Peter M, Sander S, et al.: Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2007; 92: 2581\u20139","DOI":"10.1210\/jc.2006-2890"},{"key":"10.3238\/arztebl.m2021.0009_ref31","doi-asserted-by":"crossref","unstructured":"S\u00f6rensen L, von D\u00f6beln U, Ahlmann H, et al.: Expanded screening of one million Swedish babies with R4S and CLIR for post-analytical evaluation of data. Int J Neonatal Screen 2020; 6: 42","DOI":"10.3390\/ijns6020042"},{"key":"10.3238\/arztebl.m2021.0009_ref32","doi-asserted-by":"crossref","unstructured":"Tangeraas T, S\u00e6ves I, Klingenberg C, et al.: Performance of expanded newborn screening in Norway supported by post-analytical bioinformatics tools and rapid second-tier DNA analyses. Int J Neonatal Screen 2020; 6: 51","DOI":"10.3390\/ijns6030051"},{"key":"10.3238\/arztebl.m2021.0009_ref33","doi-asserted-by":"crossref","unstructured":"R\u00f6schinger W, Sonnenschein S, Schumann E, Nennstiel-Ratzel U, Roscher AA, Olgem\u00f6ller B: Neue Zielerkrankungen im Neugeborenenscreening Empfehlungen aus einem Pilotprojekt. Monatsschr Kinderheilkd 2015; 2: 142\u20139","DOI":"10.1007\/s00112-014-3297-0"},{"key":"10.3238\/arztebl.m2021.0009_ref34","doi-asserted-by":"crossref","unstructured":"Gramer G, Hauk F, Lobitz S, Sommerburg O, Speckmann C, Hoffmann GF: Neugeborenenscreening 2020. Monatsschr Kinderheilkd 2017; 165: 216\u201325","DOI":"10.1007\/s00112-016-0233-5"},{"key":"10.3238\/arztebl.m2021.0009_ref35","doi-asserted-by":"crossref","unstructured":"Ojodu J, Singh S, Kellar-Guenther Y, et al.: NewSTEPs: the establishment of a national newborn screening technical assistance resource center. Int J Neonatal Screen 2018; 4: 1 MEDLINE","DOI":"10.3390\/ijns4010001"},{"key":"10.3238\/arztebl.m2021.0009_ref36","unstructured":"van der Ploeg K, Wins S, Verkerk PH. The newborn blood spot screening in the Netherlands monitor 2018. www.rivm.nl\/sites\/default\/files\/2020-01\/HielprikMon2018-Engelstalig.pdf (last accessed on 15 July 2020)."},{"key":"10.3238\/arztebl.m2021.0009_ref37","unstructured":"Begum F: Newborn Blood Spot Screening Programme in the UK. Data collection and performance analysis report 2016 to 2017. Published May 2018. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/709367\/Newborn_blood_spot_screening_data_collection_and_performance_analysis_report_2016_to_2017.pdf (last accessed on 15 July 2020)."},{"key":"10.3238\/arztebl.m2021.0009_ref38","doi-asserted-by":"crossref","unstructured":"Lobitz S, Fr\u00f6mmel C, Brose A, Klein J, Blankenstein O: Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany. Eur J Hum Genet 2014; 22: 1051\u20133","DOI":"10.1038\/ejhg.2013.286"},{"key":"10.3238\/arztebl.m2021.0009_ref39","doi-asserted-by":"crossref","unstructured":"Fr\u00f6mmel C, Brose A, Klein J, Blankenstein O, Lobitz S: Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants. Biomed Res Int 2014; 2014: 695828","DOI":"10.1155\/2014\/695828"},{"key":"10.3238\/arztebl.m2021.0009_ref40","doi-asserted-by":"crossref","unstructured":"Vill K, K\u00f6lbel H, Schwartz O, et al.: One year of newborn screening for SMA \u2013 results of a German pilot project. J Neuromuscul Dis 2019; 6: 503\u20131","DOI":"10.3233\/JND-190428"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2021.0009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T09:36:40Z","timestamp":1638783400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2021.0009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2021.0009","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]}}}